Filing Details

Accession Number:
0001209191-23-035256
Form Type:
4
Zero Holdings:
No
Publication Time:
2023-06-07 21:22:07
Reporting Period:
2023-06-05
Accepted Time:
2023-06-07 21:22:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1396814 Pacira Biosciences Inc. PCRX Pharmaceutical Preparations (2834) 510619477
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1928278 Daryl Gaugler C/O Pacira Biosciences
5401 West Kennedy Boulevard, Suite 890
Tampa FL 33609
Chief Operating Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2023-06-05 1,000 $38.74 23,591 No 4 S Direct
Common Stock Disposition 2023-06-06 1,005 $38.99 22,586 No 4 S Direct
Common Stock Disposition 2023-06-07 1,047 $37.87 21,539 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the reporting person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934.
  2. Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.